| AASLD

Home

Late‐Breaking Abstracts ‐ Presented at the 70th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting™ 2019

Read more about Late‐Breaking Abstracts ‐ Presented at the 70th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting™ 2019

29 November 2019

Cover Image

Read more about Cover Image

29 November 2019

Joseph F. Pisa, Robert S. Brown, Lauren M. Yang, Daryl T.Y. Lau, Brett E. Fortune, Sayed Obaidullah Aseem, Robert E. Schwartz, Nicholas Russo, Vikas Gupta, Muhammad Amir, Giorgio Roccaro, Nidhi Jalan‐Sakrikar, Enis Kostallari, Amaia Navarro‐Corcuera – 29 November 2019

The North American Consortium for the Study of End‐Stage Liver Disease–Acute‐on‐Chronic Liver Failure Score Accurately Predicts Survival: An External Validation Using a National Cohort

Read more about The North American Consortium for the Study of End‐Stage Liver Disease–Acute‐on‐Chronic Liver Failure Score Accurately Predicts Survival: An External Validation Using a National Cohort

Russell Rosenblatt, Nicole Shen, Zaid Tafesh, Shirley Cohen‐Mekelburg, Carl V. Crawford, Sonal Kumar, Catherine Lucero, Robert S. Brown, Arun Jesudian, Brett E. Fortune – 29 November 2019 – Acute‐on‐chronic liver failure (ACLF) carries high short‐term mortality. The North American Consortium for the Study of End‐Stage Liver Disease (NACSELD)–ACLF score, positive if ≥2 organ failures are present, is a bedside tool that predicts short‐term mortality in patients with cirrhosis.

Extensive Thrombectomy as a Legitimate Strategy in Living Donor Liver Transplantation With Advanced Portal Vein Thrombosis

Read more about Extensive Thrombectomy as a Legitimate Strategy in Living Donor Liver Transplantation With Advanced Portal Vein Thrombosis

Sami Akbulut, Sezai Yilmaz – 28 November 2019

Acute Liver Failure in Children: Is It Time to Revise the Diagnostic Criteria?

Read more about Acute Liver Failure in Children: Is It Time to Revise the Diagnostic Criteria?

Angelo Di Giorgio, Lorenzo D’Antiga – 28 November 2019

Lipotoxic Hepatocyte‐Derived Exosomal MicroRNA 192‐5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease

Read more about Lipotoxic Hepatocyte‐Derived Exosomal MicroRNA 192‐5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease

Xiao‐Lin Liu, Qin Pan, Hai‐Xia Cao, Feng‐Zhi Xin, Ze‐Hua Zhao, Rui‐Xu Yang, Jing Zeng, Huiping Zhou, Jian‐Gao Fan – 28 November 2019

Endothelial Bone Morphogenetic Protein 2 (Bmp2) Knockout Exacerbates Hemochromatosis in Homeostatic Iron Regulator (Hfe) Knockout Mice but not Bmp6 Knockout Mice

Read more about Endothelial Bone Morphogenetic Protein 2 (Bmp2) Knockout Exacerbates Hemochromatosis in Homeostatic Iron Regulator (Hfe) Knockout Mice but not Bmp6 Knockout Mice

Xia Xiao, Som Dev, Susanna Canali, Abraham Bayer, Yang Xu, Aneesh Agarwal, Chia‐Yu Wang, Jodie L. Babitt – 28 November 2019

The von Willebrand Factor Facilitates Model for End‐Stage Liver Disease–Independent Risk Stratification on the Waiting List for Liver Transplantation

Read more about The von Willebrand Factor Facilitates Model for End‐Stage Liver Disease–Independent Risk Stratification on the Waiting List for Liver Transplantation

Georg P. Györi, David Pereyra, Benedikt Rumpf, Hubert Hackl, Christoph Köditz, Gregor Ortmayr, Thomas Reiberger, Michael Trauner, Gabriela A. Berlakovich, Patrick Starlinger – 27 November 2019

Subscribe to